Close Menu

An article looks at how state stem cell funding in California will pan out as the CIRM is about to start doling out major awards for building renovations at state campuses and newly created institutions like the San Diego Consortium for Regenerative Medicine. "The consortium is an example of how California's philanthropists have become heavily involved in shaping the agency — and how scientists, in turn, have tapped into the state's private wealth," says a news feature.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.